RNAC
Cartesian Therapeutics, Inc. - Common Stock (RNAC)
$04
About Cartesian Therapeutics, Inc. - Common Stock (RNAC)
Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company was founded on December 10, 2007 is headquartered in Frederick, MD.
Details
Daily high
$8.19
Daily low
$7.96
Price at open
$8.19
52 Week High
$11.00
52 Week Low
$5.60
Market cap
247.8M
Dividend yield
-
Volume
17,515
Avg. volume
124,492
P/E ratio
-1.38
Cartesian Therapeutics, Inc. - Common Stock News
Details
Daily high
$8.19
Daily low
$7.96
Price at open
$8.19
52 Week High
$11.00
52 Week Low
$5.60
Market cap
247.8M
Dividend yield
-
Volume
17,515
Avg. volume
124,492
P/E ratio
-1.38